Cognitive outcomes after brain blood vessel malformation treatment
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial tests whether a minimally invasive procedure to block a specific type of abnormal connection between brain blood vessels can help preserve or improve memory and thinking. It is being studied in people who have not yet had bleeding from this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a type of brain blood vessel malformation called an unruptured dural arteriovenous fistula (dAVF), confirmed by an angiogram
- Your doctor plans to treat the malformation with a minimally invasive procedure called endovascular embolization (a catheter inserted through a blood vessel to block the problem)
- You are able to have a brain MRI scan
- You have not had bleeding in the brain from this condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
This trial uses your medical images (like MRI or angiography) to create a personalized map of your brain's blood vessels. The goal is to help doctors better plan minimally invasive treatments for aneurysms or arteriovenous malformations.
This study looks at how brain arteriovenous malformations (abnormal connections between arteries and veins in the brain) behave over time, and how different treatment choices affect outcomes. It may help researchers better predict prognosis and guide future care.
This study checks people long-term after a procedure called embolization, which blocks abnormal blood vessel connections in the brain (arteriovenous malformations). It may help doctors learn how well the treatment lasts over time and what outcomes to expect.
This trial studies a device that delivers a special “embolic” material (often described as glue) to treat a type of abnormal connection in the brain’s blood vessels (dAVF). It may help by blocking the leaking or risky blood flow, and it will be compared against how doctors handle eligible cases with other embolic materials.
This research study uses special brain imaging scans to understand how an unruptured arteriovenous malformation (an abnormal tangle of blood vessels in the brain) affects blood flow and thinking abilities before and after surgical treatment. The goal is to learn how surgery impacts brain function and cognition in patients like you.
Hear when a new Glymphatic System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.